USPTO Official Misleads Congress on Permissible Scope of Compulsory Licenses to Increase Access to Medicines
In testimony before the U.S. House of Representatives Subcommittee on Intellectual Property, Competition and the Internet on 27 June 2012 (Hearing: Protecting Patents, Trade Secrets, and Market Access), the Deputy Director of the U.S. Patent and Trademark Office, who also serves…